References
1. Ama Buskwofie, Gizelka David-West, Camille A Clare. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020 Apr;112(2):229-32.
2. Marc Arbyn, Elisabete Weiderpass, Laia Bruni, Silvia de Sanjosé, Mona Saraiya, Jacques Ferlay, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb ;8(2): e191-e203.
3. Burzawa J, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther. 2015; 15:805–10.
4. J.K. Chan, V. Loizzi, R.A. Burger, J. Rutgers, B.J. Monk. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer. 2003 Feb; 97(3):568-74.
5. J.-M. Lee, K.-B. Lee, J.-H. Nam, S.-Y. Ryu, D.-S. Bae, J.-T. Park, et al. Prognostic factors in FIGO stage IB–IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol. 2008 Feb;19(2):321-6.
6. Anastasia Prodromidou, David L Phelps, Vasilios Pergialiotis, Paula Cunnea, Nikolaos Thomakos , Alexandros Rodolakis, et al. Clinicopathological characteristics and survival outcomes of patients with large cell neuroendocrine carcinoma of the uterine cervix: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022 Mar; 270: 212-20.
7. The NCCN clinical practice guidelines in oncology cervical cancer (version 1.2022) [EB/OL]. Fort Washington: NCCN,2022[2021-10-26]. https://www.nccn.org
8. Yuanyuan Zhang, Yi Huang, Suiyu Luo, Lin Li, Hongying Yang, Ziyi Wang, et al. Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study. Int J Gynaecol Obstet. 2022 Sep;158(3):722-29.
9. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. 4th ed. IARC. Lyon, France: International Agency for Research on Cancer, 2014:10-40.
10. Pedro T Ramirez, Michael Frumovitz, Rene Pareja, Aldo Lopez, Marcelo Vieira, Reitan Ribeiro, et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med; 2018 Nov 15;379(20):1895-1904.
11. Albores-Saavedra J, Martinez-Benitez B, Luevano E. Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol. 2008 Jul; 27(3): 333–9.
12. Suthida Intaraphet, Nongyao Kasatpibal, Sumalee Siriaunkgul, Mette Sogaard, Jayanton Patumanond, Surapan Khunamornpong, et al. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma. Asian Pac J Cancer Prev. 2013;14(9):5355-60.
13. Vincent Vinh-Hung, Claire Bourgain, Georges Vlastos, Gábor Cserni, Mark De Ridder, Guy Storme, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer. 2007 Aug 23;7:164.
14. Benjamin Margolis, Ana I Tergas, Ling Chen, June Y Hou, William M Burke, Jim C Hu, et al. natural History and Outcome of Neuroendocrine Carcinoma of the Cervix. Gynecol Oncol. 2016 May; 141(2): 247–54.
15. Brooke E Howitt, Paul Kelly, W Glenn McCluggage. Pathology of Neuroendocrine Tumours of the Female Genital Tract. Curr Oncol Rep. 2017 Sep;19(9):59.
16. Joshua G Cohen, Daniel S Kapp, Jacob Y Shin, Renata Urban, Alexander E Sherman, Lee-may Chen, et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am. J. Obstet. Gynecol. 2010 Oct; 203(4): 347.e1-6.
17. Clemens B Tempfer, Iris Tischoff, Askin Dogan, Ziad Hilal, Beate Schultheis, Peter Kern, et al. Neuroendocrine carcinoma of the cervix: a systematic review of the literature. BMC Cancer. 2018 May ;18(1): 530.
18. Xuan Pei, Libing Xiang, Shuang Ye, Tiancong He, Yufan Cheng, Wentao Yang, et al. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix. Gynecol Oncol. 2017 Dec;147(3):589-96.
19. Anastasia Prodromidou, David L Phelps, Vasilios Pergialiotis, Paula Cunnea, Nikolaos Thomakos, Alexandros Rodolakis, et al. Clinicopathological characteristics and survival outcomes of patients with large cell neuroendocrine carcinoma of the uterine cervix: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022 Mar; 270:212-20.
20. L. Lan-Fang, S. Hai-Yan, Y. Zuo-Ming, Z. Jian-Qing, C. Ya-Qing. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases. Eur J Gynaecol Oncol. 2012; 33(1):68-73.
21. Qian Zhang, Yao Xiong, Jiaxiang Ye, Liying Zhang, Li Li. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis. PLoS One. 2018 Apr 11;13(4): e0192784.
22. William Small Jr, Monica A Bacon, Amishi Bajaj, Linus T Chuang, Brandon J Fisher, Matthew M Harkenrider, et al. Cervical cancer: A global health crisis. Cancer. 2017 Jul;123(13):2404-2412.
23. Lei Yuan, Hongyuan Jiang, Yin Lu, Sun-Wei Guo, Xishi Liu. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix. Int J Gynecol Cancer. 2015 Sep; 25(7):1315-21.
24. Jian Chen, Yang Sun, Li Chen, Lele Zang, Cuibo Lin, Yongwei Lu, et al. Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients. Peer J. 2021 Jul ;9:e11563.
25. Ju-Hyun Kim, Seung-Hyuk Shim, So-Hyun Nam, Shin-Wha Lee, Jeong-Yeol Park, Dae-Yeon Kim, et al. Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix. J Minim Invasive Gynecol. 2020 Nov-Dec;27(7):1558-1565.
26. S Tangjitgamol, P T Ramirez, C C Sun, H T See, A Jhingran, J J Kavanagh, et al. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer. 2005 Jul-Aug;15(4):646-56.
27. Arshad H Rahmani, Ali Yousif Babiker, Mohammed A Alsahli, Saleh A Almatroodi, Nazik Elmalaika O S Husain. Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma. Open Access Maced J Med Sci. 2018 Feb ;6(2):263-268.
28. Xiaoyu Ji, Lei Sui, Kejuan Song, Teng Lv, Han Zhao, Qin Yao. PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer. Cancer Med. 2021 Jul;10(14):4743-4751.
29. Leora Horn, Aaron S Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J Hochmair, et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018 Dec ;379(23):2220-2229.